Change search criteria ↓

Search results

828 projects found matching your search criteria:

  1. 1. Novel model for in vitro analyzing breast cancer, colorectal cancer and prostate cancer cells.

    Principal investigator: prof. Piotr Rieske

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: OPUS 1, Panel: NZ4

  2. 2. Herstories and histories of illness. On embodied cancer remission narratives in breast cancer and prostate cancer suppor…

    Principal investigator: Katarzyna Barbara Słaby

    Uniwersytet Jagielloński, Wydział Filozoficzny

    Call: PRELUDIUM 15, Panel: HS6

  3. 3. Parallel microevolution of metabolic plasticity and chemoresistance of cancer cells: a key to understanding cancer relap…

    Principal investigator: prof. Jarosław Piotr Czyż

    Uniwersytet Jagielloński

    Call: OPUS 28, Panel: NZ3

  4. 4. Cancer-Omics. Vibrational Imaging and Endospectroscopy Takes Cancer Research to the Next Level

    Principal investigator: prof. Halina Abramczyk

    Politechnika Łódzka, Wydział Chemiczny

    Call: OPUS 17, Panel: ST4

  5. 5. Identification, enumeration, epithelial status and clinical value of circulating cancer stem-like cells in different sub…

    Principal investigator: dr Małgorzata Szostakowska-Rodzoś

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie

    Call: PRELUDIUM 17, Panel: NZ5

  6. 6. Role of white adipose tissue browning in cancer associated cachexia of patients with gastric cancer

    Principal investigator: dr hab. Marek Jerzy Sierżęga

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum

    Call: OPUS 14, Panel: NZ4

  7. 7. The role of cancer stem cells in extracellular matrix production and drug resistance in ovarian cancer

    Principal investigator: dr hab. Radosław Januchowski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

    Call: SONATA BIS 6, Panel: NZ5

  8. 8. Cancer stem cells signaling pathways as a therapeutic terget in ovarian cancer chemotherapy

    Principal investigator: prof. Maciej Zabel

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

    Call: OPUS 7, Panel: NZ5

  9. 9. An innovative approach to the elimination of cancer cells in disseminated ovarian cancer in various preclinical models b…

    Principal investigator: dr hab. Joanna Ewa Jazowiecka-Rakus

    Kardio-Med Silesia Sp. z o.o.

    Call: OPUS 28, Panel: NZ5

  10. 10. Targeting Energy Metabolism for Precision Cancer Therapy: Novel Inhibitors of LDH-A and PDK1 as Potential Strategies to …

    Principal investigator: Marika Anna Frańczak

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: PRELUDIUM 22, Panel: NZ7

  11. 11. Investigating the anti-cancerous effect of antioxidant extract from spent coffee grounds on the functioning of normal an…

    Principal investigator: Adrianna Maria Piasek

    Politechnika Warszawska, Wydział Chemiczny

    Call: PRELUDIUM 22, Panel: NZ5

  12. 12. Role of microparticles derived from platelets and cancer cells in colorectal cancer progression – how to stop them or tu…

    Principal investigator: prof. Maria Anna Kowalska

    Instytut Biologii Medycznej PAN

    Call: OPUS 24, Panel: NZ5

  13. 13. A smart stride for cancer: synergistic effect of co-delivery chemo- andphototherapeutic agents using magneto-fluorescent…

    Principal investigator: dr Prachi Uttam Ghoderao

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: POLONEZ BIS 2, Panel: NZ7

  14. 14. Dendritic Gold Nanostructures Decorated Graphene as an Electrochemical Biosensor towards Cancer Biomarker CA 125 for the…

    Principal investigator: dr Jincymol Kappen

    Politechnika Śląska, Wydział Chemiczny

    Call: POLONEZ BIS 2, Panel: ST5

  15. 15. Light-producing, oxygen-delivering, cancer cell-targeted carriers for photosensitisers dedicated for photodynamic therap…

    Principal investigator: prof. Marek Arkadiusz Murias

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: OPUS 22, Panel: NZ7

  16. 16. Exploring new roles for ADAR1 in cancer; generation of novel neoantigens, links with p53 and the effects of cancer treat…

    Principal investigator: dr Małgorzata Kurkowiak

    Uniwersytet Gdański, Międzynarodowe Centrum Badań nad Szczepionkami Przeciwnowotworowymi

    Call: WEAVE-UNISONO, Panel: NZ2

  17. 17. The effect of cancer somatic mutations in miRNA genes on the functioning of these genes and their potential role in canc…

    Principal investigator: dr Paulina Małgorzata Gałka-Marciniak

    Instytut Chemii Bioorganicznej PAN

    Call: SONATA 16, Panel: NZ2

  18. 18. The 'omics' of renal cancer nucleolus: towards identification of new cancer markers and therapeutic targets.

    Principal investigator: prof. Agnieszka Piekiełko-Witkowska

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO, Szkoła Nauk Medycznych

    Call: OPUS 18, Panel: NZ5

  19. 19. Potential function of visfatin/NAMPT in the anoikis resistance of human ovarian cancer: novel insight into obesity-reala…

    Principal investigator: dr Justyna Karolina Gogola-Mruk

    Uniwersytet Jagielloński, Wydział Biologii

    Call: PRELUDIUM 17, Panel: NZ5

  20. 20. The role of vitamin D in the action of macrophages on cancer cells in murine mammary gland cancer model

    Principal investigator: Artur Anisiewicz

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: PRELUDIUM 13, Panel: NZ5

  21. 21. Deciphering malignancy of cancer cells outside the primary tumors through molecular characterization of single circulati…

    Principal investigator: dr Aleksandra Markiewicz

    Gdański Uniwersytet Medyczny, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

    Call: SONATA 11, Panel: NZ3

  22. 22. SLC6A14 - an amino acid transporter upregulated in cancer: Role of chaperone proteins in transporter exit from endoplasm…

    Principal investigator: prof. Katarzyna Anna Nałęcz

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

    Call: OPUS 10, Panel: NZ3

  23. 23. Understanding cancer stem cells heterogeneity and plasticity and its role in the progression of oral cancer.

    Principal investigator: dr hab. Agnieszka Kobielak

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

    Call: OPUS 9, Panel: NZ5

  24. 24. Analysis of relations on the level of metabolome, miRNome, and transcriptome of human renal cancer: towards identificati…

    Principal investigator: dr hab. Agnieszka Piekiełko-Witkowska

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

    Call: OPUS 7, Panel: NZ5

  25. 25. Cancer progression- the role of tumor-derived microfragments (oncosomes) as messangers in communication between tumor ce…

    Principal investigator: dr Rafał Michał Szatanek

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

    Call: OPUS 4, Panel: NZ6

  26. 26. Analysis of immungenecity and therapeutic activity of cell cancer vaccines based on cancer stem cells and induced plurip…

    Principal investigator: prof. Andrzej Mackiewicz

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski II

    Call: OPUS 4, Panel: NZ6

  27. 27. Regulation of ALKBH proteins expression in cancer and its role in cancer therapy.

    Principal investigator: prof. Elżbieta Grzesiuk

    Instytut Biochemii i Biofizyki PAN

    Call: OPUS 2, Panel: NZ4

  28. 28. Effect of parabens and their mixtures on selected parameters related to the development of breast cancer in models og ho…

    Principal investigator: Anna Maria Wróbel

    Uniwersytet Jagielloński, Wydział Biologii i Nauk o Ziemi; Instytut Zoologii

    Call: PRELUDIUM 1, Panel: NZ7

  29. 29. The role of oncogenic ras in deregulation of BNIP3 protein in hypoxic cancer cells. Implication for cancer cell survival…

    Principal investigator: prof. Leon Strządała

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: OPUS 1, Panel: NZ4

  30. 30. Development of dual immuno-oligo- biosensors for monitoring and controlling of the metastatic colorectal cancer and inve…

    Principal investigator: dr hab. Magdalena Stobiecka

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Instytut Biologii

    Call: OPUS 25, Panel: ST4

  31. 31. Investigating mechanisms regulating ALCAM alternative splicing and susceptibility of this molecule to cleavage by shedda…

    Principal investigator: dr Marta Karolina Wagner

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: OPUS 25, Panel: NZ2

  32. 32. Reversible senescence as a new mechanism of cancer cell resistance for chemotherapy. Analysis of the mechanism of cancer…

    Principal investigator: dr Karolina Anna Staniak

    Politechnika Warszawska, Wydział Chemiczny

    Call: SONATINA 5, Panel: NZ3

  33. 33. Intratumor heterogeneity and its role in cancer progression and prognosis; a study based on molecular imaging of cancer …

    Principal investigator: prof. Piotr Michał Widłak

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

    Call: OPUS 12, Panel: NZ4

  34. 34. The use of microRNA inhibitors for restoration of the physiological expression of sodium iodide symporter NIS in thyroid…

    Principal investigator: Marta Elżbieta Kotlarek

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

    Call: PRELUDIUM 7, Panel: NZ2

  35. 35. Doses and biological responses in thyroid gland, lungs, testes and bladder during radiotherapy of laryngeal cancer and p…

    Principal investigator: prof. Julian Malicki

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Nauk o Zdrowiu; Zakład Elektroradiologii

    Call: OPUS 1, Panel: NZ4

  36. 36. IDENTIFICATION OF NEW CANCER-RELATED GENES THAT PLAY AN IMPORTANT ROLE IN COMMON HUMAN CANCERS

    Principal investigator: dr hab. Piotr Kozłowski

    Politechnika Poznańska, Wydział Informatyki

    Call: OPUS 1, Panel: NZ5

  37. 37. Evaluation of the relationship between doxorubicin resistance, epithelial-mesenchymal plasticity, and effects of selecte…

    Principal investigator: Dominika Kunachowicz

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

    Call: PRELUDIUM 23, Panel: NZ5

  38. 38. Identification of the adipogenic niche derived molecules as the factors driving the colorectal cancer cell progression

    Principal investigator: dr hab. Dorota Nowak

    Uniwersytet Wrocławski, Wydział Biotechnologii

    Call: OPUS 22, Panel: NZ3

  39. 39. Analysis of a mechanism, mediators and sequence of events in the context of an assessment of stimulatory effect of senes…

    Principal investigator: dr hab. Krzysztof Stefan Książek

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski II

    Call: OPUS 2, Panel: NZ3

  40. 40. Molecular pathways involved in nuclear membrane stress adaptation and its role in breast and prostate cancer

    Principal investigator: dr Paulina Nastały

    Gdański Uniwersytet Medyczny

    Call: OPUS 29, Panel: NZ3

  41. 41. New strategy for overcoming resistance to chemotherapy of ovarian cancer by modulation of the canonical and non-canonica…

    Principal investigator: prof. Radosław Januchowski

    Uniwersytet Zielonogórski, Collegium Medicum

    Call: OPUS 22, Panel: NZ5

  42. 42. CD73 (ecto-5'-nucleotidase) function in breast cancer progression and promotion, and its assessment as a therapeutic tar…

    Principal investigator: dr hab. Patrycja Małgorzata Koszałka

    Gdański Uniwersytet Medyczny, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

    Call: OPUS 14, Panel: NZ5

  43. 43. LLT1 as a regulator of the immune response and a dual-target immunotherapy approach in colorectal cancer directed at NK …

    Principal investigator: dr Marzena Dorota Lenart

    Uniwersytet Jagielloński

    Call: OPUS 29, Panel: NZ6

  44. 44. Next-Generation Exosome Therapy: Engineering NK Cell-Derived Vesicles for Targeted Cancer Treatment

    Principal investigator: dr Daria Nawrocka

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: SONATINA 9, Panel: NZ6

  45. 45. Environmental modulation of CDK4/6 inhibitor efficacy: Impact of mycotoxin alternariol exposure on anti-cancer therapies

    Principal investigator: dr Anna Dominika Walczak-Szeffer

    Uniwersytet Medyczny w Łodzi

    Call: SONATA 20, Panel: NZ5

  46. 46. Molecular factors and pathomechanism of cancer-associated cachexia.

    Principal investigator: dr hab. Marcin Tomasz Skrzypski

    Gdański Uniwersytet Medyczny

    Call: OPUS 27, Panel: NZ5

  47. 47. Defining the transcriptional and epigenetic state of tumor cells with increased plasticity and the epithelial-endothelia…

    Principal investigator: dr hab. Agnieszka Kobielak

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

    Call: OPUS 26, Panel: NZ5

  48. 48. In search for DNA methylation aberrations associated with susceptibility to ovarian cancer

    Principal investigator: dr Malwina Magdalena Suszyńska

    Instytut Chemii Bioorganicznej PAN

    Call: OPUS 26, Panel: NZ5

  49. 49. How is meiotic TEX12 re-activated in cancer and can we exploit this in the clinic?

    Principal investigator: dr Urszula Łucja Mcclurg

    Instytut Biologii Medycznej PAN

    Call: SONATA BIS 13, Panel: NZ3

  50. 50. Predictive Potential of Circulating MicroRNA Biomarkers in Patients with High Familial or Genetic Risk of Cancer

    Principal investigator: prof. Wojciech Fendler

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: OPUS 25, Panel: NZ5

Graphic design and implementation: Jakub Piotrowski